DexCom, Inc. (DXCM)
73.74
+1.40
(+1.94%)
USD |
NASDAQ |
May 29, 16:00
73.70
-0.04
(-0.05%)
After-Hours: 20:00
DexCom Free Cash Flow : 1.429B for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Insulet Corp. | 387.80M |
| Abbott Laboratories | 7.378B |
| Baxter International, Inc. | 714.00M |
| Boston Scientific Corp. | 3.475B |
| Globus Medical, Inc. | 605.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 525.60M |
| Cash from Investing (Quarterly) | -298.50M |
| Cash from Financing (Quarterly) | -25.00M |
| Free Cash Flow Per Share (Quarterly) | 1.141 |
| Free Cash Flow to Equity (Quarterly) | 453.90M |
| Free Cash Flow to Firm (Quarterly) | 451.29M |
| Free Cash Flow Yield | 4.82% |